World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
136
Citations
76429
World Ranking
1964
National Ranking
1115

Sholom Wacholder publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Sholom Wacholder sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 424 publications — 44th percentile

44% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Sholom Wacholder D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Sholom Wacholder sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 136 D-Index — 90th percentile

90% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Research.com Recognitions

  • 1996 - Fellow of the American Statistical Association (ASA)

Overview

Sholom Wacholder was affiliated with the National Institutes of Health in the United States and contributed extensively to medical research, particularly in the domain of epidemiology and infectious diseases. Their work primarily focused on the intersection of infectious agents and cancer, with a strong emphasis on cervical cancer and human papillomavirus (HPV) research.

The scientist's research spanned several disciplines within medicine, including epidemiology, microbiology, physiology, surgery, and obstetrics and gynecology. The main areas of investigation included:

  • Cervical Cancer and HPV Research
  • Hepatitis B Virus Studies
  • Reproductive tract infections research
  • Syphilis Diagnosis and Treatment
  • Genital Health and Disease
  • Endometrial and Cervical Cancer Treatments
  • Animal Virus Infections Studies

Their published works appeared in various reputable venues, with notable contributions to:

  • UNC Libraries
  • Nature Communications
  • The Lancet Oncology
  • The Journal of Infectious Diseases
  • npj Vaccines

Among the recent papers coauthored by Wacholder were studies that investigated the immune landscape of bacterial vaginosis and its relationship with HPV infection, analyses of precancerous cervical lesions post-vaccination, and exploration of HPV vaccine efficacy. Select notable publications include:

  • "molBV reveals immune landscape of bacterial vaginosis and predicts human papillomavirus infection natural history" (2022, Nature Communications)
  • "Precancerous cervical lesions caused by non-vaccine-preventable HPV types after vaccination with the bivalent AS04-adjuvanted HPV vaccine: an analysis of the long-term follow-up study from the randomised Costa Rica HPV Vaccine Trial" (2022, The Lancet Oncology)
  • "Risk Factors for Non-Human Papillomavirus (HPV) Type 16/18 Cervical Infections and Associated Lesions Among HPV DNA-Negative Women Vaccinated Against HPV-16/18 in the Costa Rica Vaccine Trial" (2020, The Journal of Infectious Diseases)
  • "HPV16 infection decreases vaccine-induced HPV16 antibody avidity: the CVT trial" (2022, npj Vaccines)
  • "Estimating human papillomavirus vaccine efficacy from a single-arm trial: proof-of-principle in the Costa Rica Vaccine Trial" (2023, JNCI Journal of the National Cancer Institute)

Wacholder collaborated frequently with several researchers, including Carolina Porras, Rolando Herrero, Allan Hildesheim, Aimée R. Kreimer, and Douglas R. Lowy. These collaborations reflected a significant body of work centered around infectious diseases and cancer epidemiology.

In recognition of their professional contributions, Sholom Wacholder was named a Fellow of the American Statistical Association (ASA) in 1996.

Best Publications

  • Human papillomavirus and cervical cancer

    Mark Schiffman;Philip E Castle;Jose Jeronimo;Ana C Rodriguez

  • The Risk of Cancer Associated with Specific Mutations of BRCA1 and BRCA2 among Ashkenazi Jews

    Jeffery P. Struewing;Patricia Hartge;Sholom Wacholder;Sonya M. Baker

  • Associations of elevated interleukin-6 and C-reactive protein levels with mortality in the elderly

    Tamara B Harris;Luigi Ferrucci;Russell P Tracy;M.Chiara Corti

  • Assessing the Probability That a Positive Report is False: An Approach for Molecular Epidemiology Studies

    Sholom Wacholder;Stephen Chanock;Montserrat Garcia-Closas;Laure El ghormli

  • Epidemiologic Evidence Showing That Human Papillomavirus Infection Causes Most Cervical Intraepithelial Neoplasia

    Mark H. Schiffman;Heidi M. Bauer;Robert N. Hoover;Andrew G. Glass

  • A genome-wide association study identifies alleles in FGFR2 associated with risk of sporadic postmenopausal breast cancer

    David J Hunter;David J Hunter;Peter Kraft;Kevin B Jacobs;David G Cox

  • Replicating genotype–phenotype associations

    Stephen J. Chanock;Teri Manolio;Michael Boehnke;Eric Boerwinkle

  • The Elevated 10-Year Risk of Cervical Precancer and Cancer in Women With Human Papillomavirus (HPV) Type 16 or 18 and the Possible Utility of Type-Specific HPV Testing in Clinical Practice

    Michelle J. Khan;Philip E. Castle;Attila T. Lorincz;Sholom Wacholder

  • Selection of Controls in Case-Control Studies I. Principles

    Sholom Wacholder;Joseph K. McLaughlin;Debra T. Silverman;Jack S. Mandel

  • Genome-wide association study of prostate cancer identifies a second risk locus at 8q24

    Meredith Yeager;Nick Orr;Richard B Hayes;Kevin B Jacobs

  • Multiple loci identified in a genome-wide association study of prostate cancer

    Gilles Thomas;Kevin B Jacobs;Meredith Yeager;Meredith Yeager;Peter Kraft

  • Human Papillomavirus Testing in the Prevention of Cervical Cancer

    Mark Schiffman;Nicolas Wentzensen;Sholom Wacholder;Walter Kinney

  • Population-Based Study of Human Papillomavirus Infection and Cervical Neoplasia in Rural Costa Rica

    Rolando Herrero;Allan Hildesheim;Concepcion Bratti;Mark E. Sherman

  • The relation of risk factors to the development of atherosclerosis in saphenous-vein bypass grafts and the progression of disease in the native circulation. A study 10 years after aortocoronary bypass surgery.

    Lucien Campeau;Marc Enjalbert;Jacques Lespérance;Martial G. Bourassa

  • Selection of Controls in Case-Control Studies: II. Types of Controls

    Sholom Wacholder;Debra T. Silverman;Joseph K. McLaughlin;Jack S. Mandel

  • Effect of human papillomavirus 16/18 L1 viruslike particle vaccine among young women with preexisting infection: a randomized trial.

    Allan Hildesheim;Rolando Herrero;Sholom Wacholder;Ana C. Rodriguez

  • HPV DNA testing in cervical cancer screening. Results from women in a high-risk province of Costa Rica.

    Mark Schiffman;Rolando Herrero;Allan Hildesheim;Mark E. Sherman

  • Estimation of effect size distribution from genome-wide association studies and implications for future discoveries

    Ju Hyun Park;Sholom Wacholder;Mitchell H. Gail;Ulrike Peters

  • NAT2 slow acetylation, GSTM1 null genotype, and risk of bladder cancer: results from the Spanish Bladder Cancer Study and meta-analyses.

    Montserrat García-Closas;Núria Malats;Debra Silverman;Mustafa Dosemeci

  • Genome-wide association study of prostate cancer identifies a second risk locus at 8q24

    Adam S. Kibel

Frequent Co-Authors

Mark Schiffman
Mark Schiffman National Institutes of Health
Rolando Herrero
Rolando Herrero Costa Rican Agency for Biomedical Research, INCIENSA Foundation
Allan Hildesheim
Allan Hildesheim National Institutes of Health
Robert D. Burk
Robert D. Burk Albert Einstein College of Medicine
Stephen J. Chanock
Stephen J. Chanock National Institutes of Health
Mark E. Sherman
Mark E. Sherman Mayo Clinic
Margaret A. Tucker
Margaret A. Tucker National Institutes of Health
David J. Hunter
David J. Hunter Harvard University
Meredith Yeager
Meredith Yeager Hood College
Neil E. Caporaso
Neil E. Caporaso National Institutes of Health

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring a career in Medicine goes beyond traditional MD programs. Today, a growing number of students are taking advantage of flexible online degrees, which offer accelerated paths and specialized training for in-demand healthcare roles.

For nurses aiming to reach leadership levels, the fastest dnp online program options provide advanced education with a quicker time to completion. If you prefer lighter clinical requirements, there are also online dnp programs without clinicals that can help you expand your qualifications while balancing other commitments.

If you're eager to start working in healthcare sooner, a 6 month lpn program online allows licensing as a practical nurse in a matter of months. On the other hand, for those interested in mental health care, psych np online programs offer speedy, accredited pathways to becoming a Psychiatric Nurse Practitioner.

These online options offer convenience and flexibility, making them ideal for busy students or working professionals eager to advance their medical careers.

Best Scientists Citing Sholom Wacholder

Recently Published Articles